NO20090311L - Anvendelse av PPD for adjuvantering av en nukleinsyrevaksine - Google Patents

Anvendelse av PPD for adjuvantering av en nukleinsyrevaksine

Info

Publication number
NO20090311L
NO20090311L NO20090311A NO20090311A NO20090311L NO 20090311 L NO20090311 L NO 20090311L NO 20090311 A NO20090311 A NO 20090311A NO 20090311 A NO20090311 A NO 20090311A NO 20090311 L NO20090311 L NO 20090311L
Authority
NO
Norway
Prior art keywords
ppd
adjuvanting
nucleic acid
nukleinsyrevaksiner
beskrives
Prior art date
Application number
NO20090311A
Other languages
English (en)
Norwegian (no)
Inventor
Jean-Yves Bonnefoy
Stephane Paul
Jean-Marc Limacher
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of NO20090311L publication Critical patent/NO20090311L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20090311A 2006-06-20 2009-01-20 Anvendelse av PPD for adjuvantering av en nukleinsyrevaksine NO20090311L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06360026 2006-06-20
US85301906P 2006-10-20 2006-10-20
PCT/EP2007/005261 WO2007147518A2 (en) 2006-06-20 2007-06-14 Use of ppd for the adjuvantation of a nucleic acid vaccine

Publications (1)

Publication Number Publication Date
NO20090311L true NO20090311L (no) 2009-01-20

Family

ID=38740511

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090311A NO20090311L (no) 2006-06-20 2009-01-20 Anvendelse av PPD for adjuvantering av en nukleinsyrevaksine

Country Status (10)

Country Link
US (1) US20090317422A1 (de)
EP (1) EP2040748A2 (de)
JP (1) JP2009541235A (de)
KR (1) KR20090018968A (de)
AU (1) AU2007263355A1 (de)
CA (1) CA2652457A1 (de)
IL (1) IL195496A0 (de)
MX (1) MX2008016031A (de)
NO (1) NO20090311L (de)
WO (1) WO2007147518A2 (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223739B1 (en) * 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
US6846808B1 (en) * 1996-05-01 2005-01-25 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
DE10042598A1 (de) * 2000-08-30 2002-03-28 Gsf Forschungszentrum Umwelt Rekombinantes MVA mit der Fähigkeit zur Expression des HER-2/Neu-GENS
US20020086837A1 (en) * 2000-12-21 2002-07-04 Jack Gauldie Acne vaccine
JP3492671B2 (ja) 2002-04-18 2004-02-03 理化学研究所 免疫アジュバント
WO2004007664A2 (en) * 2002-05-28 2004-01-22 Maxygen, Inc. Nucleic acid vectors
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma

Also Published As

Publication number Publication date
JP2009541235A (ja) 2009-11-26
WO2007147518A3 (en) 2008-03-06
IL195496A0 (en) 2011-08-01
EP2040748A2 (de) 2009-04-01
WO2007147518A2 (en) 2007-12-27
CA2652457A1 (en) 2007-12-27
US20090317422A1 (en) 2009-12-24
MX2008016031A (es) 2009-01-19
KR20090018968A (ko) 2009-02-24
AU2007263355A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
CY1122812T1 (el) Δοσολογικο σχημα για εναν αγωνιστη του υποδοχεα s1p
NO20093146L (no) Amino-pyridinderivater som S1P1/EDG1-reseptoragonister
EA201001491A1 (ru) Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
DE602008004794D1 (de) 1',3'-disubstituierte 4-phenyl-3,4,5,6-tetrahydro-2h,1'h-ä1,4'übipyridinyl-2'-one
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201070853A1 (ru) Кристаллический (r)-2-(4-циклопропансульфонилфенил)-n-пиразин-2-ил-3-(тетрагидропиран-4-ил)пропионамид
DOP2010000328A (es) Inhibidores de bace
GEP20227397B (en) Inhibitors of influenza viruses replication
DK2315756T3 (da) 1,2,5-oxadiazoler som inhibitorer af indolamin-2,3-dioxygenase
BRPI0914682B8 (pt) compostos de heteroarila e composições compreendendo os referidos compostos
NO20083462L (no) Nye tiofenderivater som S1P1/EDG1-reseptoragonister
EP2056861A4 (de) Impf-immuntherapie
DK3133070T3 (da) Eliglustat (genz 112638) som inhibitor af glucosylceramidsyntase til anvendelse i en fremgangsmåde til behandling af fabrys eller gauchers sygdom, hvilken fremgangsmåde omfatter justering af den individuelle terapeutiske dosis i forhold til patientens p-450-metabolisme
JP2011517716A5 (de)
WO2012067866A8 (en) Multivalent vaccine for filariasis
MX338827B (es) Composicion de vacuna para uso contra influenza.
EA201170680A1 (ru) Ингибиторы акт и p70 s6-киназы
EA201001045A1 (ru) Модифицированный вирус гриппа
BRPI0811499A2 (pt) Métodos para purificar um vírus ou antígeno viral, e para preparar uma vacina contra um vírus ou antígeno viral.
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
CO6571898A2 (es) Composición pesticida y su uso

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application